ATEC Spine (ATEC): Debts to Book Capitalization

Brandmark of Alphatec Holdings (ATEC)

Alphatec Holdings, Inc. (ATEC) profitability relies on physician commitment and the effective implementation of implant software, with the indicator standing at 52.27. High capacity of modernized CNC shops ensures an uninterrupted output of products. This price chart on GURU.Markets, serving as the primary assessment tool, complements an analysis complicated by quality-related litigation and innovation costs amid market competition.

ATEC - Alphatec Corp Debts to Net Assets over the range 07/04/2022 - 10/28/2026
Original product of Alphatec Holdings

Analyzing the balance between borrowed funds and equity is critical for assessing the stability of equity assets. This total debt-to-book value ratio measures the degree of financial leverage, which for Alphatec Holdings, Inc. (ATEC) represents a search for a compromise between costly robotics for implant production and the risk of excessive debt load, as reflected in the price action of this chart.

Competitors of Alphatec Holdings, Inc.

BSX: Debts to Book Capitalization|Debts to Book Value edwards.com EW|RMD: Debts to Book Capitalization|PODD - Debt to Book Value|Zimmer Biomet - Debts to Book Capitalization|CooperSurgical (COO) - Debts to Net Assets|ALGN (Align Technology, Inc.) - Debts to Book Capitalization|Debts to Book Capitalization GMED|Debt to Book Capitalization Ratio TransMedics Organ Care System (TMDX)|Debt to Book Capitalization Ratio CryoLife (AORT)|Debts to Book Capitalization ENOV|IART - Debts to Net Assets|Debt to Book Value Establishment Labs|BBNX - Debts to Book Capitalization Ratio|Debts to Book Capitalization IRMD|Embecta Corp (EMBC) - Debts to Book Value|Debts to Book Capitalization Tandem Diabetes (TNDM)|Debt to Book Value Ratio Axogen Surgical (AXGN)|SI-BONE, Inc. (SIBN) - Debt to Book Value|Debt to Net Assets Ratio OFIX (orthofix.com)|Bioventus - Debt to Book Capitalization Ratio|Debt to Book Value OrthoPediatrics Corp KIDS|TMCI (Treace Medical) - Debts to Book Capitalization|SRTA - Debts to Book Value|Debts to Book Capitalization Carlsmed Inc|rxsight.com (RXST) - Debt to Book Value Ratio|CLPT: Debts to Book Capitalization|Debts to Net Assets Stereotaxis Inc|Debts to Book Capitalization STIM (NeuroStar)|Debt to Book Value Sight Sciences Inc (SGHT)|Debts to Book Capitalization OBIO (Orchestra BioMed, Inc.)|Anika Therapeutics Inc. - Debts to Book Capitalization|NSPR - Debt to Book Capitalization Ratio|Jin Medical International (ZJYL) - Debt to Book Capitalization Ratio|Debt to Book Value vivani.com VANI|Xtant Medical (XTNT) - Debt to Net Assets Ratio|Debts to Book Capitalization NMTC (NeuroOne Medical Technologies)|Debts to Book Value MODD|MYO: Debt to Book Capitalization Ratio|Debt to Net Assets Envoy Medical Inc. COCH|Debt to Book Value VVOS (Vivos Therapeutics, Inc)|Debts to Book Capitalization enVVeno Corp NVNO|Debts to Book Capitalization SINT (SINTX Technologies)|TNON: Debts to Net Assets|Debt to Book Capitalization Ratio Lifeward (LFWD)|AMIX (Autonomix Medical) - Debts to Book Capitalization Ratio|Debt to Book Capitalization Ratio IVF|Debt to Book Value Bone Biologics Inc|Axonics, Inc. - Debts to Book Capitalization|Debts to Book Value BIOL (biolase.com)|DYNT - Debt to Book Capitalization Ratio|FNA - Debt to Book Value Ratio|Debt to Book Value INVO Bio INVO